ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion 登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。

MBIO Mustang Bio Inc

0.7629
0.0129 (1.72%)
2024年6月19日 - 終了
15分遅延
名称 銘柄コード 市場 種別
Mustang Bio Inc MBIO NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
0.0129 1.72% 0.7629 08:59:59
始値 安値 高値 終値 前日終値
0.97 0.741 1.30 0.8501 0.75
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/6/1721:30GLOBEMustang Bio Announces Favorable Efficacy and Safety Data..
2024/6/1313:15EDGAR2Form EFFECT - Notice of Effectiveness
2024/6/0706:00EDGAR2Form 8-K - Current report
2024/6/0509:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/6/0509:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/6/0106:09EDGAR2Form S-3 - Registration statement under Securities Act of..
2024/5/2205:15EDGAR2Form 8-K - Current report
2024/5/1319:01EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
2024/5/0305:01GLOBEMustang Bio Announces Closing of $4 Million Public Offering
2024/4/3009:00GLOBEMustang Bio Announces Pricing of $4 Million Public Offering
2024/3/2822:00GLOBEMustang Bio Announces Vision for CAR T-Cell Therapy Platform..
2024/3/1205:30EDGAR2Form 8-K - Current report
2024/3/1205:05GLOBEMustang Bio Reports Full-Year 2023 Financial Results and..
2024/3/1205:02EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
2024/3/0721:30GLOBEMustang Bio Announces Publication in Nature Medicine of Data..
2024/2/1506:15EDGAR2Form 8-K - Current report
2024/1/2606:07EDGAR2Form 8-K - Current report
2024/1/1122:30GLOBEMustang Bio to Participate in the B. Riley Securities 4th..
2024/1/0506:05EDGAR2Form 8-K - Current report
2023/12/2006:06EDGAR2Form 3 - Initial statement of beneficial ownership of..
2023/12/1211:52EDGAR2Form S-1 - General form for registration of securities under..
2023/12/1122:37EDGAR2Form 8-K - Current report
2023/12/1122:30GLOBEMustang Bio Presents Updated Phase 1/2 Multicenter Clinical..
2023/11/1506:44EDGAR2Form 8-K - Current report
2023/11/1506:05GLOBEMustang Bio Reports Third Quarter 2023 Financial Results and..
2023/11/0305:05EDGAR2Form 8-K - Current report
2023/11/0222:28GLOBEMustang Bio Announces MB-106 CD20-Targeted CAR-T Data..
2023/10/3103:57EDGAR2Form 8-K - Current report
2023/10/3103:15GLOBEMustang Bio Announces Closing of $4.4 Million Registered..
2023/10/3023:30EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2023/10/2705:05EDGAR2Form 8-K - Current report
2023/10/2701:30GLOBEMustang Bio Announces $4.4 Million Registered Direct..
2023/10/2622:00GLOBEMustang Bio Announces FDA Acceptance of IND Application for..
2023/10/0505:05EDGAR2Form 8-K - Current report
2023/8/1621:56EDGAR2Form 8-K - Current report
2023/8/1505:10EDGAR2Form 8-K - Current report
2023/8/1505:01GLOBEFortress Biotech Reports Second Quarter 2023 Financial..
2023/8/1505:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/7/3121:40EDGAR2Form 8-K - Current report
2023/7/2106:30EDGAR2Form 8-K - Current report
2023/7/1121:05EDGAR2Form 8-K - Current report
2023/7/0805:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/6/3021:05EDGAR2Form 8-K - Current report

最近閲覧した銘柄

Delayed Upgrade Clock